Global AI based Clinical Trial Solution Provider Market
報告摘要
The global Global AI based Clinical Trial Solution Provider Market is set to witness considerable expansion over the coming years.
At its core, AI based Clinical Trial Solution Provider pertains to The process, clinical trials are a very crucial that enable both innovators and regulators to assess the efficacy of a candidate drug, use of AI in clinical trial save the time and cost efficiencies b. Stakeholders across the technology and communications landscape are growingly turning to these solutions to meet contemporary demands.
Growth is fueled by a convergence of factors: rising awareness among end users, continuous product innovation, and the growing emphasis on efficiency and sustainability within the technology and communications sector.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, fueled by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global AI-based Clinical Trial Solution Providers Market Snapshot
Chapter 4. Global AI-based Clinical Trial Solution Providers Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Key AI in Healthcare Companies
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of COVID 19 on CRO Industry
Chapter 5. Market Segmentation 1: Target Therapeutic Area Estimates & Trend Analysis
5.1. Target Therapeutic Area & Market Share, 2020 & 2028
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following Target Therapeutic Area:
5.2.1. Cardiovascular Disorders
5.2.2. CNS Disorders
5.2.3. Infectious Disorders
5.2.4. Metabolic Disorders
5.2.5. Oncological Disorders
5.2.6. Other Disorders
Chapter 6. Market Segmentation 2: Trial Phase Estimates & Trend Analysis
6.1. Trial Phase & Market Share, 2020& 2028
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following Trial Phase:
6.2.1. Early Phase 1
6.2.2. Phase 1
6.2.3. Phase 2
6.2.4. Phase 3
6.2.5. Phase 4
Chapter 7. Market Segmentation 3: End-Users Estimates & Trend Analysis
7.1. End-Users & Market Share, 2020 & 2028
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following End-Users:
7.2.1. Pharmaceutical Companies
7.2.2. Academia and Other Users
Chapter 8. AI-based Clinical Trial Solution Providers Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America AI-based Clinical Trial Solution Providers Market revenue (US$ Million) estimates and forecasts by Target Therapeutic Area, 2020-2028
8.1.2. North America AI-based Clinical Trial Solution Providers Market revenue (US$ Million) estimates and forecasts by Trial Phase, 2020-2028
8.1.3. North America AI-based Clinical Trial Solution Providers Market revenue (US$ Million) estimates and forecasts by End-Users, 2020-2028
8.1.4. North America AI-based Clinical Trial Solution Providers Market revenue (US$ Million) estimates and forecasts by country, 2020-2028
8.2. Europe
8.2.1. Europe AI-based Clinical Trial Solution Providers Market revenue (US$ Million) by Target Therapeutic Area, 2020-2028
8.2.2. Europe AI-based Clinical Trial Solution Providers Market revenue (US$ Million) by Trial Phase, 2020-2028
8.2.3. Europe AI-based Clinical Trial Solution Providers Market revenue (US$ Million) by End-Users, 2020-2028
8.2.4. Europe AI-based Clinical Trial Solution Providers Market revenue (US$ Million) by country, 2020-2028
8.3. Asia Pacific
8.3.1. Asia Pacific AI-based Clinical Trial Solution Providers Market revenue (US$ Million) by Target Therapeutic Area, 2020-2028
8.3.2. Asia Pacific AI-based Clinical Trial Solution Providers Market revenue (US$ Million) by Trial Phase, 2020-2028
8.3.3. Asia Pacific AI-based Clinical Trial Solution Providers Market revenue (US$ Million) by End-Users, 2020-2028
8.3.4. Asia Pacific AI-based Clinical Trial Solution Providers Market revenue (US$ Million) by country, 2020-2028
8.4. Latin America
8.4.1. Latin America AI-based Clinical Trial Solution Providers Market revenue (US$ Million) by Target Therapeutic Area, (US$ Million)
8.4.2. Latin America AI-based Clinical Trial Solution Providers Market revenue (US$ Million) by Trial Phase, (US$ Million)
8.4.3. Latin America AI-based Clinical Trial Solution Providers Market revenue (US$ Million) by End-Users, 2020-2028
8.4.4. Latin America AI-based Clinical Trial Solution Providers Market revenue (US$ Million) by country, 2020-2028
8.5. Middle East & Africa
8.5.1. Middle East & Africa AI-based Clinical Trial Solution Providers Market revenue (US$ Million) by Target Therapeutic Area, (US$ Million)
8.5.2. Middle East & Africa AI-based Clinical Trial Solution Providers Market revenue (US$ Million) by Trial Phase, (US$ Million)
8.5.3. Middle East & Africa AI-based Clinical Trial Solution Providers Market revenue (US$ Million) by End-Users
8.5.4. Middle East & Africa AI-based Clinical Trial Solution Providers Market revenue (US$ Million) by country, 2020-2028
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Antidote Technologies, Inc.
9.2.2. AiCure, LLC
9.2.3. Deep 6 AI
9.2.4. Deep Lens Inc.
9.2.5. GNS Healthcare
9.2.6. Innoplexus
9.2.7. Intelligencia.ai
9.2.8. MEDIAN Technologies
9.2.9. Mendel.ai
9.2.10. Phesi
9.2.11. Saama Technologies
9.2.12. Unlearn.AI, Inc.
9.2.13. Trials.ai
9.2.14. Concerto HealthAI
9.2.15. PathAI
9.2.16. OWKIN, INC.
9.2.17. Accutar Biotechnology Inc.
9.2.18. Atomwise, Inc.
9.2.19. BenevolentAI
9.2.20. Berg LLC
9.2.21. Berkeley Lights, Inc.
9.2.22. BioAge Labs, Inc.
9.2.23. Biovista Inc.
9.2.24. C4X Discovery Holdings Plc
9.2.25. Clinithink Ltd
9.2.26. Cloud Pharmaceuticals, Inc.
9.2.27. Cyclica, Inc.
9.2.28. CytoReason
9.2.29. Deep Genomics Inc.
9.2.30. DeepThink Health Inc.
9.2.31. e-therapeutics plc
9.2.32. Envisagenics, Inc.
9.2.33. Exscientia Limited
9.2.34. Insilico Medicine
9.2.35. Lantern Pharma Inc.
9.2.36. Medable, Inc.
9.2.37. Mind the Byte
9.2.38. NuMedii, Inc
9.2.39. Nuritas, Ltd.
9.2.40. Recursion Pharmaceuticals, Inc.
9.2.41. Schrödinger, LLC
9.2.42. Symphony Innovation, LLC
9.2.43. TARA Biosystems, Inc.
9.2.44. twoXAR, Incorporated
9.2.45. Verge Analytics, Inc.
9.2.46. Winterlight Labs Inc.
9.2.47. WuXi Nextcode Genomics
9.2.48. XtalPi Inc.
9.2.49. Other Prominent Player
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們